MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 37 filers reported holding MEI PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $106,000 | -15.2% | 73,394 | +3.2% | 0.00% | – |
| Q3 2016 | $125,000 | +28.9% | 71,110 | -0.1% | 0.00% | – |
| Q2 2016 | $97,000 | +6.6% | 71,171 | -1.8% | 0.00% | – |
| Q1 2016 | $91,000 | -27.2% | 72,447 | -7.3% | 0.00% | – |
| Q4 2015 | $125,000 | +5.9% | 78,163 | +3.8% | 0.00% | – |
| Q3 2015 | $118,000 | -10.6% | 75,299 | -2.6% | 0.00% | – |
| Q2 2015 | $132,000 | +8.2% | 77,291 | +13.7% | 0.00% | – |
| Q1 2015 | $122,000 | -52.3% | 67,987 | +13.4% | 0.00% | – |
| Q4 2014 | $256,000 | -5.9% | 59,944 | +52.0% | 0.00% | – |
| Q3 2014 | $272,000 | +14.3% | 39,447 | +5.2% | 0.00% | – |
| Q2 2014 | $238,000 | -93.7% | 37,507 | -88.9% | 0.00% | -100.0% |
| Q1 2014 | $3,749,000 | +45.0% | 336,835 | +4.4% | 0.00% | 0.0% |
| Q4 2013 | $2,585,000 | -16.1% | 322,727 | +17.9% | 0.00% | 0.0% |
| Q3 2013 | $3,080,000 | +78.3% | 273,795 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $1,727,000 | – | 242,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |